- Location
1
result for "
Cardioxane
"-
Clinigen Has Acquired Cardioxane (Dexrazoxane) From Novartis for $33m
Apr 6, 2013Clinigen has acquired Cardioxane (dexrazoxane) from Novartis for $33m, which is payable in two tranches. As per the agreement, Clinigen will manufacture, register, distribute, and commercialize the product in countries where current ...
Tags: Clinigen, Cardioxane, Medicine
